ANVISA’s New Rules for Post-Market Monitoring of Cosmetics: The Impact of RDC 894/2024

ANVISA's New Rules for Post-Market Monitoring of Cosmetics: The Impact of RDC 894/2024

The National Health Surveillance Agency (ANVISA) has published two documents on the new rules for post-market monitoring of cosmetics. The Inspection Manual for Good Cosmetic Surveillance Practices and the Questions and Answers on RDC 894/2024 will support the implementation of the new regulatory guidelines and strengthen the safety of cosmetic products in Brazil.

ANVISA Publishes Database for Clinical Investigations into Medical Devices

ANVISA Publishes Database for Clinical Investigations into Medical Devices

The National Health Surveillance Agency (ANVISA) has announced the launch of a database aimed at clinical investigations related to medical devices. This initiative represents an important milestone in the health sector, promoting greater transparency, efficiency and safety in research carried out in Brazil.

Exploring the Diversity of Medical Devices for Health Promotion in Brazil

Overview: Brazil stands out as the main market for medical devices in Latin America, with an established, albeit complex, regulatory system. Medical products in the country are regulated by the National Health Surveillance Agency (ANVISA). Against this backdrop, we explore the main types of medical devices and their specific applications within the Brazilian context. Introduction: […]

Health Product Labelling Requirements for Imported Products into Brazil

"Discover the critical role that packaging plays in the development of cosmetic products."

The import of Health products into Brazil is subject to various regulations, with proper labelling being a crucial part of this procedure. These regulations cover the current standards for labelling imported products, outlining the responsibilities of importers and the essential elements that must be included on labels.